C21 · Pharmaceuticals · Global
Cumulative cell and gene therapy launches
Global: 76 in end of 2023.
- 76 Latest · Global · end of 2023
- Irregular Release cadence
- 1 Record · 1 region · 2023
Verified 15 Sep 2026 · 1 publisher
The figure
One published observation so far. A chart follows as soon as a second period is published.
Cumulative cell and gene therapy launches
Global, end of 2023
Every record
1 record · 1 region · 2023. Each period links to its record: the value, its source evidence and original document.
| Period | Value | Source | Type |
|---|---|---|---|
| Global 1 record | |||
| end of 2023 | 76 | IQVIA · 31 Dec 2023 | |
Download this data
Every file carries its provenance: the CSV has a source column per row, and the chart images print the publisher, the licence and this page's address under the drawing. Source: IQVIA. Licence: CC BY 4.0.
Use and publication rights
- View, cite and link: free
Quote any number, cite this page or a single record, and link to it anywhere.
- Copy, chart and republish: free with attribution
The data is published under CC BY 4.0, commercial use included. Credit StatOrigin and the original publisher (IQVIA); the chart files already carry that line.
- The source documents: the publisher's terms
Figures are facts read from the publishers' own documents. The documents themselves, their text and design, stay under each publisher's terms; follow the source links for those.
How this measure is built
- Definition
- Total number of cell and gene therapies launched commercially to date.
- Measure
- One slice of Novel active substance launches ( basis: cumulative, form: count, segment: cell and gene therapy ) . Total number of novel active substances launched on the market. Region and period are columns on every record, not slices.
- Limitations
- Values are shown as published; StatOrigin does not revise, fill gaps or convert currencies.
- Verification
- Each value, unit, period and place was checked against its source evidence before publication. See the methodology and the corrections process.
Sources · 1 document
| Document | Publisher | Published | Data points |
|---|---|---|---|
| Strengthening Pathways for Cell and Gene Therapies: Current State and Future Scenarios | IQVIA | — | 1 |
Other slices of novel active substance launches
- Novel active substance launches 6
- Oncology novel active substance (NAS) launches (cumulative) 6 cumulative · oncology
- Oncology novel active substance (NAS) launches (annual) 3 oncology
- First-in-class novel active substance launches 2 first in class
- Novel active substance launches, five-year total 2 cumulative
- Chemically synthesized share of new medicine launches 1 chemical
- Domestic-only oncology NAS launches (cumulative) 1 cumulative · domestic · oncology
- Expected annual novel active substance launches (lower bound) 1 forecast low
- Expected annual novel active substance launches (upper bound) 1 forecast high
- Expected cumulative novel active substance launches (lower bound) 1 cumulative · forecast low
- Expected cumulative novel active substance launches (upper bound) 1 cumulative · forecast high
- Genetically engineered share of new medicine launches 1 biologic
Frequently asked questions
What is the latest cumulative cell and gene therapy launches?
Global: 76 in end of 2023.
Where does this data come from?
From 1 document published by IQVIA. Every figure on this page links to its record, which preserves the original source evidence.
How often is it updated?
Irregularly: the publishers behind this measure do not release it on a fixed schedule. A new figure appears here once it is published and verified.
Can I use this data?
Yes. StatOrigin publishes it under CC BY 4.0: you may copy, chart and republish it, including commercially, with attribution to StatOrigin and to the original publisher.
Cite this page
Cite the page as a data set, or open any record to cite one figure: each record carries APA, MLA, Chicago and BibTeX forms that credit the original publisher.
StatOrigin. (2026). Cumulative cell and gene therapy launches [Data set]. Retrieved October 28, 2026, from https://statorigin.org/indicators/cumulative-cell-and-gene-therapy-launches
"Cumulative cell and gene therapy launches." StatOrigin, 2026, https://statorigin.org/indicators/cumulative-cell-and-gene-therapy-launches. Accessed 28 Oct. 2026.
StatOrigin. "Cumulative cell and gene therapy launches." Data set, 2026. Accessed October 28, 2026. https://statorigin.org/indicators/cumulative-cell-and-gene-therapy-launches.
@misc{statorigin_cumulative_cell_and_gene_therapy_launches_2026, title = {Cumulative cell and gene therapy launches}, author = {{StatOrigin}}, year = {2026}, url = {https://statorigin.org/indicators/cumulative-cell-and-gene-therapy-launches}, note = {Data set. Accessed 2026-10-28} }